Inverse and Direct Cancer Comorbidity in People with Central Nervous System Disorders: A Meta-Analysis of Cancer Incidence in 577,013 Participants of 50 Observational Studies | Zendy

Ferrán Catalá-López | Zendy; Marta SuárezPinilla | Zendy; Paula SuárezPinilla | Zendy; José M Valderas | Zendy; Manuel Gómez-Beneyto | Zendy; Salvador Martı́nez | Zendy; Vicent BalanzáMartínez | Zendy; Joan Climent | Zendy; Alfonso Valencia | Zendy; John J. McGrath | Zendy; Benedicto CrespoFacorro | Zendy; José SánchezMoreno | Zendy; Eduard Vieta | Zendy; Rafael TabarésSeisdedos | Zendy

Open Access

Inverse and Direct Cancer Comorbidity in People with Central Nervous System Disorders: A Meta-Analysis of Cancer Incidence in 577,013 Participants of 50 Observational Studies

Author(s) -

Ferrán Catalá-López,

Marta SuárezPinilla,

Paula SuárezPinilla,

José M Valderas,

Manuel Gómez-Beneyto,

Salvador Martı́nez,

Vicent BalanzáMartínez,

Joan Climent,

Alfonso Valencia,

John J. McGrath,

Benedicto CrespoFacorro,

José SánchezMoreno,

Eduard Vieta,

Rafael TabarésSeisdedos

Publication year - 2014

Publication title -

psychotherapy and psychosomatics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.531

H-Index - 98

eISSN - 1423-0348

pISSN - 0033-3190

DOI - 10.1159/000356498

Subject(s) - medicine , comorbidity , cancer , meta analysis , schizophrenia (object oriented programming) , disease , confidence interval , incidence (geometry) , psychiatry , oncology , physics , optics

There is a lack of scientific consensus about cancer comorbidity in people with central nervous system (CNS) disorders. This study assesses the co-occurrence of cancers in patients with CNS disorders, including Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), autism spectrum disorders, Down's syndrome (DS), Huntington's disease (HD), multiple sclerosis (MS), Parkinson's disease (PD) and schizophrenia (SCZ).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research